查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1702018

单株抗体市场报告（按生产方法、来源、适应症、最终用途和地区）2025 年至 2033 年

Monoclonal Antibodies Market Report by Production Method, Source, Indication, End Use, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2024年全球单株抗体市场规模达2,358亿美元。展望未来， IMARC Group预计到2033年市场规模将达到4,107亿美元，2025-2033年期间的成长率（CAGR）为6.04%。癌症、自体免疫疾病和传染病等慢性疾病的盛行率不断上升、双特异性抗体和抗体-药物偶联物 (ADC) 等创新、老年人口的增加以及肿瘤学和免疫疗法的扩展正在推动市场成长。

单株抗体 (mAb) 是实验室产生的蛋白质，用作替代抗体，可增强、改变、恢復和模仿免疫系统对有害细胞的攻击。它们用于检测和瞄准癌细胞，并透过增强免疫系统来摧毁它们。它们也用于阻断癌细胞与促进细胞生长的蛋白质之间的连接。此外，它们还能阻止蛋白质的形成，使免疫系统细胞能够有效地对抗癌细胞。此外，单株抗体可将放射治疗直接输送至癌细胞，并最大限度地减少辐射对健康细胞的影响

单株抗体市场趋势：

目前，癌症、心臟病、中风、糖尿病和关节炎等慢性病的盛行率不断上升是推动市场发展的关键因素之一。除此之外，领先的製造商正在大力投资研发 (R&D) 活动，以推出增强型 mAb 药物来治疗神经退化性疾病，如阿兹海默症、亨廷顿氏症、帕金森氏症和路易氏体疾病。他们也专注于各种行销策略来扩大客户群，这有助于市场的成长。此外，用于治疗各种抗原（如癌细胞、免疫抑制和免疫调节分子）的人源化 mAb 的需求不断增加，为行业投资者提供了丰厚的成长机会。除此之外，全球对用于治疗癌症的具有成本效益的生物相似药 mAb 的需求也在增加。这一趋势与蓬勃发展的医疗保健产业一起推动着市场的成长。此外，下一代定序等各种基因平台的技术进步正在带来积极的市场前景。此外，全球先进基因工程技术在 mAb 生产中的应用正在增加。再加上大众对 mAb 疗法益处的认识不断提高，推动了市场的成长。

本报告回答的关键问题

  • 2024 年全球单株抗体市场规模？ 2025-2033年全球单株抗体市场的预期成长率是多少？
  • 推动全球单株抗体市场发展的关键因素有哪些？
  • COVID-19 对全球单株抗体市场有何影响？
  • 根据生产方法，全球单株抗体市场如何分布？
  • 根据来源，全球单株抗体市场的分布如何？
  • 根据适应症，全球单株抗体市场如何分布？
  • 根据最终用途，全球单株抗体市场如何分布？
  • 全球单株抗体市场的主要区域有哪些？
  • 全球单株抗体市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球单株抗体市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依生产方式

  • 体内
  • 体外

第七章：市场区隔：依来源

  • 鼠类
  • 嵌合
  • 人性化
  • 人类

第八章：市场区隔：依指标

  • 癌症
  • 自体免疫疾病
  • 发炎性疾病
  • 传染病
  • 其他的

第 9 章：市场区隔：最终用途别

  • 医院
  • 研究机构
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AbbVie Inc.
    • Amgen Inc.
    • Biogen Inc.
    • F. Hoffmann-La Roche AG
    • GSK plc
    • Johnson & Johnson
    • Merck KGaA
    • Novartis AG
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Sanofi SA
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A6278

The global monoclonal antibodies market size reached USD 235.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 410.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.04% during 2025-2033. The rising prevalence of chronic disorders such as cancer, autoimmune disorders, and infectious diseases, innovations like bispecific antibodies and antibody-drug conjugates (ADCs), increasing geriatric population, and the expansion in oncology and immunotherapy are propelling the market growth.

Monoclonal antibodies (mAbs) are laboratory-produced proteins used to serve as substitute antibodies that can enhance, modify, restore, and mimic the attack of the immune system on unwanted cells. They are utilized for detecting and targeting cancer cells for destruction by enhancing the immune system. They are also employed to block the connection between a cancer cell and proteins that promote cell growth. In addition, they prevent the formation of proteins for enabling immune system cells to work efficiently against cancer cells. Besides this, mAbs transport the radiation treatment directly to cancer cells and minimize the effect of radiation on healthy cells

Monoclonal Antibodies Market Trends:

At present, the growing prevalence of chronic diseases, such as cancer, heart disease, stroke, diabetes, and arthritis, represents one of the key factors driving the market. Besides this, leading manufacturers are extensively investing in research and development (R&D) activities to introduce enhanced mAb drugs for treating neurodegenerative diseases, such as Alzheimer's, Huntington's, Parkinson's, and Lewy body diseases. They are also focusing on various marketing strategies to expand their customer base, which is contributing to the growth of the market. In addition, the increasing demand for humanized mAbs to treat various antigens, such as cancer cells, immunosuppression, and immunomodulatory molecules, are offering lucrative growth opportunities to industry investors. Apart from this, there is a rise in the demand for cost-efficient biosimilar mAbs to treat cancer across the globe. This, along with the burgeoning healthcare industry, is propelling the growth of the market. Moreover, technological advancements in various genetic platforms, such as next-generation sequencing, is offering a positive market outlook. Additionally, there is an increase in the employment of advanced genetic engineering technology in mAbs production around the world. This, coupled with the rising awareness among the masses about the benefits of mAb therapy, is bolstering the market growth.

Key Market Segmentation:

Breakup by Production Method:

  • In Vivo
  • In Vitro

Breakup by Source:

  • Murine
  • Chimeric
  • Humanized
  • Human

Breakup by Indication:

  • Cancer
  • Autoimmune Diseases
  • Inflammatory Diseases
  • Infectious Diseases
  • Others

Breakup by End Use:

  • Hospitals
  • Research Institutes
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., Biogen Inc., F. Hoffmann-La Roche AG, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global monoclonal antibodies market in 2024?
  • 2.What is the expected growth rate of the global monoclonal antibodies market during 2025-2033?
  • 3.What are the key factors driving the global monoclonal antibodies market?
  • 4.What has been the impact of COVID-19 on the global monoclonal antibodies market?
  • 5.What is the breakup of the global monoclonal antibodies market based on the production method?
  • 6.What is the breakup of the global monoclonal antibodies market based on the source?
  • 7.What is the breakup of the global monoclonal antibodies market based on the indication?
  • 8.What is the breakup of the global monoclonal antibodies market based on the end use?
  • 9.What are the key regions in the global monoclonal antibodies market?
  • 10.Who are the key players/companies in the global monoclonal antibodies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Monoclonal Antibodies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Production Method

  • 6.1 In Vivo
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 In Vitro
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Source

  • 7.1 Murine
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chimeric
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Humanized
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Human
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Autoimmune Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Inflammatory Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Infectious Diseases
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AbbVie Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Amgen Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Biogen Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 GSK plc
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Novartis AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Novo Nordisk A/S
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sanofi S.A.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Monoclonal Antibodies Market: Major Drivers and Challenges
  • Figure 2: Global: Monoclonal Antibodies Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Monoclonal Antibodies Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Monoclonal Antibodies Market: Breakup by Production Method (in %), 2024
  • Figure 5: Global: Monoclonal Antibodies Market: Breakup by Source (in %), 2024
  • Figure 6: Global: Monoclonal Antibodies Market: Breakup by Indication (in %), 2024
  • Figure 7: Global: Monoclonal Antibodies Market: Breakup by End Use (in %), 2024
  • Figure 8: Global: Monoclonal Antibodies Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Monoclonal Antibodies (In Vivo) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Monoclonal Antibodies (In Vivo) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Monoclonal Antibodies (In Vitro) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Monoclonal Antibodies (In Vitro) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Monoclonal Antibodies (Murine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Monoclonal Antibodies (Murine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Monoclonal Antibodies (Chimeric) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Monoclonal Antibodies (Chimeric) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Monoclonal Antibodies (Humanized) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Monoclonal Antibodies (Humanized) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Monoclonal Antibodies (Human) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Monoclonal Antibodies (Human) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Monoclonal Antibodies (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Monoclonal Antibodies (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Monoclonal Antibodies (Autoimmune Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Monoclonal Antibodies (Autoimmune Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Monoclonal Antibodies (Inflammatory Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Monoclonal Antibodies (Inflammatory Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Monoclonal Antibodies (Infectious Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Monoclonal Antibodies (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Monoclonal Antibodies (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Monoclonal Antibodies (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Monoclonal Antibodies (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Monoclonal Antibodies (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Monoclonal Antibodies (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Monoclonal Antibodies (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Monoclonal Antibodies (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Monoclonal Antibodies (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia-Pacific: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia-Pacific: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Monoclonal Antibodies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Monoclonal Antibodies Market: Breakup by Country (in %), 2024
  • Figure 85: Middle East and Africa: Monoclonal Antibodies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Global: Monoclonal Antibodies Industry: SWOT Analysis
  • Figure 87: Global: Monoclonal Antibodies Industry: Value Chain Analysis
  • Figure 88: Global: Monoclonal Antibodies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Monoclonal Antibodies Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Monoclonal Antibodies Market Forecast: Breakup by Production Method (in Million USD), 2025-2033
  • Table 3: Global: Monoclonal Antibodies Market Forecast: Breakup by Source (in Million USD), 2025-2033
  • Table 4: Global: Monoclonal Antibodies Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 5: Global: Monoclonal Antibodies Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 6: Global: Monoclonal Antibodies Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Monoclonal Antibodies Market: Competitive Structure
  • Table 8: Global: Monoclonal Antibodies Market: Key Players